[go: up one dir, main page]

WO2025250900A1 - Hydroglutarate de 4-hydroxy-n, n-diisopropyltryptaminium - Google Patents

Hydroglutarate de 4-hydroxy-n, n-diisopropyltryptaminium

Info

Publication number
WO2025250900A1
WO2025250900A1 PCT/US2025/031592 US2025031592W WO2025250900A1 WO 2025250900 A1 WO2025250900 A1 WO 2025250900A1 US 2025031592 W US2025031592 W US 2025031592W WO 2025250900 A1 WO2025250900 A1 WO 2025250900A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydroglutarate
hydroxy
dipt
diisopropyltryptaminium
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2025/031592
Other languages
English (en)
Inventor
Andrew R. Chadeayne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caamtech Inc
Original Assignee
Caamtech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caamtech Inc filed Critical Caamtech Inc
Publication of WO2025250900A1 publication Critical patent/WO2025250900A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne le 4-carboxybutanoate de N-(2- (4-hydroxy-1H-indol-3-yl)éthyl)-N-isopropylpropan-2-aminium (4-hydroxy-N,N-diisopropyltryptaminium), l'hydroglutarate de 4-hydroxy-N,N-diisopropyltryptaminium cristallin, et des formes cristallines spécifiques associées, y compris la forme cristalline 1 de l'hydroglutarate de 4-hydroxy-N,N-diisopropyltryptaminium, des compositions les contenant, et des procédés de traitement les utilisant.
PCT/US2025/031592 2024-05-30 2025-05-30 Hydroglutarate de 4-hydroxy-n, n-diisopropyltryptaminium Pending WO2025250900A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/653,320 2024-05-30

Publications (1)

Publication Number Publication Date
WO2025250900A1 true WO2025250900A1 (fr) 2025-12-04

Family

ID=

Similar Documents

Publication Publication Date Title
AU2022365018B2 (en) Crystalline tryptamine compounds
AU2022408191B2 (en) Psilocybin derivatives
WO2024138007A2 (fr) Dérivés de tryptamine
AU2023255767B2 (en) Crystalline quaternary salts of 4-substituted tryptamines
WO2025250900A1 (fr) Hydroglutarate de 4-hydroxy-n, n-diisopropyltryptaminium
US20250257033A1 (en) Methyl substituted quaternary tryptamine derivatives
WO2025042934A1 (fr) Fumarate de 5-méthyl-n-isopropyltryptammonium
WO2025049675A1 (fr) 5-méthoxy-tryptammonium glutarate
WO2024178051A2 (fr) Dérivés de tryptamine
WO2024206109A1 (fr) Dérivés de tryptamine
WO2025042937A1 (fr) Hydrophtalate de 5-méthoxytryptammonium
WO2025049672A1 (fr) 5-méthyl-n-isopropyltryptamine
WO2025049512A1 (fr) Hydromaléate de 5-méthyl-n-isopropyltryptammonium
WO2025049835A1 (fr) Hydrofumarate de 5-chlorotryptammonium
WO2025049837A1 (fr) Galactarate de tryptammonium
WO2025043056A1 (fr) Chlorure de 4-méthoxy-n,n-diisopropyltryptammonium
WO2025042938A1 (fr) Chlorure de 4-benzyloxy-n-méthyl-n-isopropyltryptammonium
WO2025043059A1 (fr) 4-méthoxy-n-méthyl-n-cyclopropyltryptamine
WO2025076289A1 (fr) 4-éthoxy-n-méthyl-n-isopropyltryptamine
WO2025043053A1 (fr) Chlorure de 4-méthoxy-n,n-dicyclopropyltryptammonium
WO2025049510A1 (fr) 4-hydroxy-n-éthyltryptamine
AU2023338488A1 (en) Tryptamine derivatives
AU2023285084A1 (en) 4-pivaloyloxy-n-methyltryptammonium chloride
WO2024229352A2 (fr) Dérivés de tryptamine
WO2025122474A1 (fr) 4-hydroxy-n-propyltryptamine